Global Sarcopenia treatment market is rising gradually with a steady CAGR in the forecast period of 2019-2026. The growing prevalence of sarcopenia by increasing old age population and adoption of sedentary and unhealthy lifestyle is the major factor that contributes in the growth of global sarcopenia treatment market.
Few of the major competitors currently working in the global sarcopenia treatment market are Novartis AG, AstaReal AB, Regeneron Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Biophytis, Metabolic Technologies, Inc., AbbVie Inc., Danone, Pfizer Inc., Abbott, Biogen, GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Nestlé, Mitacs, Sanofi, Bayer AG, Amway, Zydus Cadila, Eli Lilly and Company, Radius Health, Inc., MYSURABLE S.R.L., PhaseBio Pharmaceuticals, Inc among others.
Get Exclusive Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-sarcopenia-treatment-market&raksh
Global Sarcopenia Treatment Market business research report gives most appropriate and specific information to the decision makers in the Healthcare Industry which saves their time and result in excellent output. The report vigilantly analyses the potential of the market with respect to current scenario and the future prospects with respect to several industry aspects. This Sarcopenia Treatment Market report explains a number of market factors such as market estimates and forecasts, entry strategies, opportunity analysis, market positioning, competitive landscape, product positioning, market assessment and viability studies. Via this document, the best solution is offered with the systematic study of all these parameters that is performed by the experts.
Market Definition: Global Sarcopenia Treatment Market
Sarcopenia is a progressive skeletal muscle disorder. It involves the loss of muscle mass and strength due to natural aging process. This condition affects the gait and overall ability of body to perform normal tasks. According to International Osteoporosis Foundation (IOF), the muscle loss starts from the age of 40. The major causes of sarcopenia could be sedentary lifestyle, malnutrition and unhealthy food intake. The increasing population of people aged more than 60 and the increasing cases of malnutrition worldwide are the major factors augmenting the market growth.
Segmentation: Global Sarcopenia Treatment Market
Sarcopenia Treatment Market : By Treatment
- Vitamin/ Dietary Supplements
Sarcopenia Treatment Market : By Route of Administration
Sarcopenia Treatment Market: By End Users
- Specialty Clinics
Sarcopenia Treatment Market : By Distribution Channels
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Sarcopenia Treatment Market : By Geography
- North America
- South America
- Middle East & Africa
Read Complete Details with TOC Here https://www.databridgemarketresearch.com/toc?dbmr=global-sarcopenia-treatment-market&raksh
Key Developments in the Sarcopenia Treatment Market:
- In April 2019. MYSURABLE S.R.L., has developed mioTest, a system based on effective and scientifically validated tools that identifies the risk of sarcopenia. The system can also assess muscle mass composition including functionality and level of hydration of muscles in a beneficial and non-invasive way
- In April 2019, PhaseBio Pharmaceuticals, Inc. licensed ImmunoForge, Co. Ltd. the global rights for PB1023, a recombinant GLP-1 analogue used for the treatment of patients with sarcopenia. ImmunoForge, Co. Ltd. is working on a pipeline for development of novel therapies for sarcopenia related diseases. PhaseBio Pharmaceuticals, Inc. will receive development milestone payments and royalty payments on the sales of the product by this licensed agreement
Sarcopenia Treatment Market : Competitive Analysis
Global sarcopenia treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of sarcopenia treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
- The report offers Sarcopenia Treatment Market share appraisals for regional and global levels
- To gain detailed overview of parent market
- Information about key drivers, restraints, opportunities, and their impact analysis on the Sarcopenia Treatment Market size has been provided.
- The study provides an in-depth analysis of the global Sarcopenia Treatment Market and current & future trends to elucidate imminent investment pockets.
- Identify growth segments and opportunities in the industry
To Get This Report at an Attractive Cost, Click Here https://www.databridgemarketresearch.com/speak-to-analyst?dbmr=global-sarcopenia-treatment-market&raksh
About Data Bridge Market Research:
Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: [email protected]